NEUP
Price:
$7.69
Market Cap:
$14.46M
Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.
Industry
Medical - Pharmaceuticals
IPO Date
2021-12-16
Stock Exchange
NASDAQ
Ticker
NEUP
According to Neuphoria Therapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is 30.88%. This represents a change of 404.74% compared to the average of 6.12% of the last 4 quarters.
The mean historical ROE of Neuphoria Therapeutics Inc. over the last ten years is -60.98%. The current 30.88% ROE has changed -150.64% with respect to the historical average. Over the past ten years (40 quarters), NEUP's ROE was at its highest in in the March 2025 quarter at 43.32%. The ROE was at its lowest in in the December 2023 quarter at -23.03%.
Average
-60.98%
Median
-53.83%
Minimum
-147.93%
Maximum
-16.68%
Discovering the peaks and valleys of Neuphoria Therapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 786.61%
Maximum Annual ROE = -16.68%
Minimum Annual Increase = -841.11%
Minimum Annual ROE = -147.93%
Year | ROE | Change |
---|---|---|
2024 | -88.58% | -8.82% |
2023 | -97.14% | 154.08% |
2022 | -38.23% | 109.24% |
2021 | -18.27% | -67.45% |
2020 | -56.13% | 2.74% |
2019 | -54.63% | -63.07% |
2018 | -147.93% | 786.61% |
2017 | -16.68% | -57.37% |
2016 | -39.14% | -26.18% |
2015 | -53.02% | -841.11% |
The current ROE of Neuphoria Therapeutics Inc. (NEUP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-74.65%
5-year avg
-59.67%
10-year avg
-60.98%
Neuphoria Therapeutics Inc.’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neuphoria Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Neuphoria Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Neuphoria Therapeutics Inc.'s ROE?
How is the ROE calculated for Neuphoria Therapeutics Inc. (NEUP)?
What is the highest ROE for Neuphoria Therapeutics Inc. (NEUP)?
What is the 3-year average ROE for Neuphoria Therapeutics Inc. (NEUP)?
What is the 5-year average ROE for Neuphoria Therapeutics Inc. (NEUP)?
How does the current ROE for Neuphoria Therapeutics Inc. (NEUP) compare to its historical average?